Michael H Caley

Array ( [id] => 8652660 [patent_doc_number] => 08372405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Proteins with improved solubility and methods for producing and using same' [patent_app_type] => utility [patent_app_number] => 13/252671 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 9807 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719835 [patent_doc_number] => 20120009170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'METHOD OF TREATING INFLAMMATORY LUNG DISEASE WITH SUPPRESSORS OF CpG OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/237831 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11646 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009170.pdf [firstpage_image] =>[orig_patent_app_number] => 13237831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738047 [patent_doc_number] => 08409817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Methods and compositions for detection of Ehrlichia chaffeensis (VLPT)' [patent_app_type] => utility [patent_app_number] => 13/162671 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14308 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936211 [patent_doc_number] => 20110212230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Evaluating bacterial lethality of containerized food production' [patent_app_type] => utility [patent_app_number] => 13/067022 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8907 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212230.pdf [firstpage_image] =>[orig_patent_app_number] => 13067022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8339687 [patent_doc_number] => 08241610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines' [patent_app_type] => utility [patent_app_number] => 13/083385 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12193 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13083385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164971 [patent_doc_number] => 20110195092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'LIVE ATTENUATED ALDOLASE-NEGATIVE BACTERIAL VACCINE' [patent_app_type] => utility [patent_app_number] => 13/035137 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4019 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195092.pdf [firstpage_image] =>[orig_patent_app_number] => 13035137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591700 [patent_doc_number] => 08349575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Relay vaccine' [patent_app_type] => utility [patent_app_number] => 13/029884 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11133 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13029884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212369 [patent_doc_number] => 20110135669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'SYNTHETIC AGONISTS OF TLR9' [patent_app_type] => utility [patent_app_number] => 12/960030 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17257 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135669.pdf [firstpage_image] =>[orig_patent_app_number] => 12960030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323367 [patent_doc_number] => 08658386 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-02-25 [patent_title] => 'Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis' [patent_app_type] => utility [patent_app_number] => 12/951434 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10448 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12951434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007036 [patent_doc_number] => 20110059067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES' [patent_app_type] => utility [patent_app_number] => 12/941705 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4012 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059067.pdf [firstpage_image] =>[orig_patent_app_number] => 12941705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975999 [patent_doc_number] => 20110070266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS' [patent_app_type] => utility [patent_app_number] => 12/896353 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 48227 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070266.pdf [firstpage_image] =>[orig_patent_app_number] => 12896353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870891 [patent_doc_number] => 08466268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Lactobacillus sp. JNU2116 with antimutagenic activity' [patent_app_type] => utility [patent_app_number] => 12/862855 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4836 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12862855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6184010 [patent_doc_number] => 20110123561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE' [patent_app_type] => utility [patent_app_number] => 12/855671 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26799 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123561.pdf [firstpage_image] =>[orig_patent_app_number] => 12855671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858355 [patent_doc_number] => 08460890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Detection and measurement of blood-feeding activity' [patent_app_type] => utility [patent_app_number] => 12/789757 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 7543 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12789757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493843 [patent_doc_number] => 20100209448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES' [patent_app_type] => utility [patent_app_number] => 12/750329 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6078 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209448.pdf [firstpage_image] =>[orig_patent_app_number] => 12750329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493803 [patent_doc_number] => 07947290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Protease-resistant modified SEB and vaccine containing the same' [patent_app_type] => utility [patent_app_number] => 12/644952 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 5509 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947290.pdf [firstpage_image] =>[orig_patent_app_number] => 12644952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372841 [patent_doc_number] => 20100080823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants' [patent_app_type] => utility [patent_app_number] => 12/590548 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10205 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080823.pdf [firstpage_image] =>[orig_patent_app_number] => 12590548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8339921 [patent_doc_number] => 08241844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Methods and compositions for modulating an immune response with immunogenic oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/572494 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11249 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12572494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397776 [patent_doc_number] => 20090317839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'BOTULINUM TOXIN SCREENING ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/545647 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34891 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317839.pdf [firstpage_image] =>[orig_patent_app_number] => 12545647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638377 [patent_doc_number] => 20100035975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'METHODS OF PREVENTING AND TREATING RESPIRATORY VIRAL INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/510849 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13932 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035975.pdf [firstpage_image] =>[orig_patent_app_number] => 12510849 [rel_patent_id] =>[rel_patent_doc_number] =>)